GKB Ophthalmics logo

GKB Ophthalmics financials: balance sheet, profit and loss, cash flow

NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap

GKB Ophthalmics Limited · Face value ₹10
Last close ₹61.03up ₹0.83 (1.38%)BSE ₹63.88

Share price at the NSE close on 27 Oct 2026. Previous close ₹60.20.

27 Oct: open ₹61.80, high ₹63.45, low ₹56.52

52-week range of BSE trades to 27 Oct 2026
₹45.25Low, 5 Dec 2025₹76.90High, 15 Apr 2026
Market cap
₹31 Cr3,821st largest listed
P/E
9.48
P/E without one-offs
6.49
P/B
0.58
Dividend yield
Nonein the last 12 months
ROE
6.2%
ROE without one-offs
9.0%
ROCE
10.5%
Debt to equity
0.21
Volume, NSE
7,33228.7% delivered

GKB Ophthalmics' financial statements for the 10 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.GKB Ophthalmics annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
742.5Mar 1778−1.0Mar 1857−1.114Mar 1958−1.815Mar 2057−0.711Mar 21711.912Mar 22750.111Mar 2388−3.011Mar 24109−7.114Mar 251493.012Mar 26
Peak revenue ₹149 Cr, year to Mar 2026; lowest ₹57 Cr, year to Mar 2021Back to profit in the year to Mar 2026, ₹3.03 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin
6.8%−6.5%2.2%1.7%2.0%3.5%3.4%6.8%4.9%0.7%−2.6%5.8%3.3%−1.2%−1.9%−3.1%−1.3%2.7%0.2%−3.4%−6.5%2.0%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 330.0% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue149
  2. Materials and goods−105
  3. Employee costs−16
  4. Other expenses−19
  5. Operating profit8.6
  6. Depreciation−3.2
  7. Other income+2.2
  8. One-off items−1.8
  9. Finance costs−2.7
  10. Profit before tax3.2
  11. Tax−0.1
  12. Joint ventures−0.1
  13. Net profit3.0

What the company owns

  • Inventory₹55 Cr
  • Receivables₹45 Cr
  • Plant, investments and other assets₹28 Cr
  • Cash and bank₹5 Cr

What pays for it: net worth and liabilities

  • Owed to suppliers₹56 Cr
  • Net worth₹55 Cr
  • Borrowings₹12 Cr
  • Other liabilities₹9 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.GKB Ophthalmics quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 27 MayJun 2026Twelve monthsFiled 12 Aug
Revenue from operations7478575857717588109149150
7277565655667288112140140
Materials and goods bought505236373745476073105106
Employee costs––98891114171615
Other expenses––111110121314211918
Operating profit before depreciation21122541−3910
Operating margin2.2%1.7%2.0%3.5%3.4%6.8%4.9%0.7%−2.6%5.8%6.8%
Materials, % of revenue––62.2%63.5%65.2%63.2%62.8%67.7%67.4%70.7%70.9%
Employee costs, % of revenue––16.2%13.9%13.8%13.4%14.8%15.6%15.8%10.8%10.2%
Other expenses, % of revenue––19.5%19.1%17.7%16.6%17.5%16.1%19.3%12.7%12.1%
Depreciation and amortisation12443333333
Operating profit after depreciation00−2−2−121−2−657
Other income10212112123
Finance costs11112122232
Profit before one-off items and tax0−1−2−2−120−3−757
One-off items3000−10000−2−1
Profit before tax3−1−2−2−220−3−736
00000000000
Share of profit of joint ventures and associates––011000000
2−1−1−2−120−3−736
Other comprehensive income––0000000−4−4
Total comprehensive income––−1−2−120−3−7−12
Net margin3.3%−1.2%−1.9%−3.1%−1.3%2.7%0.2%−3.4%−6.5%2.0%3.7%
Net margin without joint ventures and associates––−2.1%−4.2%−2.4%2.6%0.1%−3.3%−6.7%2.1%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank. Belonging to the company's shareholders is left blank for the years to Mar 2018 and Mar 2021: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the period is a loss, which leaves no share to compare with the company's other periods. Belonging to the company's shareholders is left blank for the year to Mar 2020: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the share count moved by more than 5% across the period.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 27 May
5559666767645655
5559636363605253
Share capital55555555
Reserves5054585858554748
Belonging to outside owners of subsidiaries–0445442
1415111211111412
3741384041466271
12234466
Total assets93102107110112115125132
2829333529272624
65737476848799108
Net debt41−6−5−3−617
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 27 May
−3.75.1−2.84.2−3.4−3.8
−3.65.1−2.64.4−3.3−3.5
−6.0−0.3−6.83.0−1.1−13.2
Receivables5.40.0−8.5−0.8−2.6−21.9
Inventories−5.0−2.3−1.0−1.3−10.4−4.3
Payables1.11.7−1.89.56.014.6
Other working capital−7.60.34.5−4.45.9−1.7
Tax paid0.0−0.1−0.2−0.2−0.1−0.3
Capital spending6.34.81.72.12.11.0
Free cash flow−10.00.3−4.42.1−5.6−4.8
−6.3−3.51.4−1.72.59.0
2.8−1.7−2.2−1.60.7−5.5
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued8.00.00.00.00.00.0
Net change in cash−7.2−0.1−3.50.9−0.2−0.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.GKB Ophthalmics dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 27 May
Earnings per share₹5.92−₹2.53−₹2.38−₹4.86−₹1.80₹2.53−₹0.33−₹5.58−₹13.98₹2.42
Diluted earnings per share₹5.92−₹2.53−₹2.05−₹4.86−₹1.80–−₹0.33−₹5.58−₹13.98₹2.42
Book value per share––₹118.10₹117.55₹124.30₹125.18₹124.38₹118.58₹103.24₹104.82
Shareholder yield––––−19.3%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)55.448.242.920.041.346.454.744.030.426.5

Ratios

Consolidated, years to March.GKB Ophthalmics PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 27 May
Revenue growth–5.2%−26.7%2.3%−2.7%24.7%6.4%16.9%23.5%36.8%
Operating profit growth–−17.9%−14.7%79.9%−6.7%152.6%−24.0%−84.3%––
Net profit growth––––––−94.0%–––
––−2.0%––2.0%−0.3%−4.6%−12.6%2.3%
––––––−2.3 pts−4.3 pts−8.0 pts14.9 pts
From the net margin––––––−2.3 pts−3.6 pts−4.7 pts14.2 pts
From asset turnover––––––0.0 pts−0.6 pts−1.6 pts0.4 pts
From borrowing––––––0.0 pts−0.2 pts−1.7 pts0.3 pts
Return on capital employed––−3.5%−2.1%−1.6%2.8%1.1%−3.1%−8.3%8.1%
Cash conversion–––––260.8%−2,385.2%––−125.8%
Interest cover0.2––––1.50.5––2.0
Debt to equity––0.260.260.170.170.170.180.260.21
Receivable days––15115612510013411785110
Inventory days––285299349307298245250189
Payable days––212234234208183202195195
Cash conversion cycle, days––223221240199249160140104
Working capital days––204204184152183140116103
Asset turnover––0.610.600.540.650.680.780.911.16
Assets per rupee of net worth––1.701.721.721.731.771.852.142.45
Sales per rupee of plant––2.282.292.473.133.974.856.4010.06
Capital spending to depreciation––––2.011.780.590.720.700.32
Plant being built, % of plant in use–––0.0%5.3%15.1%20.7%21.4%22.9%25.5%
Interest cover is left blank for the years to Mar 2018, Mar 2019, Mar 2020, Mar 2021, Mar 2024 and Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.9%
Cash from operations against operating profit
−44.2%
Measure10 years5 years3 years
Revenue growth, yearly rate–21.3%25.5%
Return on equity, average–−2.6%−5.0%
Return on capital employed, average–0.1%−1.1%
Operating margin, average2.8%3.1%1.3%
Net margin, average−0.9%−1.0%−2.6%
Asset turnover, average–0.840.95
Cash conversion cycle, days, average–171135
Debt to equity, average–0.200.22

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−0.7−3.0−3.8
Cash from investing7.79.89.0
Cash from financing−10.4−6.5−5.5
Capital spending11.75.31.0
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised8.07.73.0
Borrowings repaid8.47.35.9

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––376545
Altman Z-scorePublished threshold 1.81––2.381.952.322.522.632.371.902.32
Beneish M-scorePublished threshold −1.78––––−1.53−2.59−2.13−2.73−2.82−1.54
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––8.770.371.31−4.84−5.17−1.68
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––−1.04–––
Receivables growth less revenue growthOur threshold 0 percentage points–––3.15−19.14−24.5635.81−14.55−33.7339.24
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––5.3716.54−14.56−2.94−22.712.94−35.06
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−1.870.640.521.38−1.567.78−4.11
Assets under construction, years of additionsOur threshold 2 years of additions–––0.002.161.48–1.882.053.68
Effective tax ratePublished threshold 17.16 per cent10.52––––0.1321.75––2.42
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−3.95−133.43––−8.24
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
4 Jun 2026CRISIL Ratings LimitedBank FacilitiesShort-term scaleCrisil DNo Rating Change1
4 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleCrisil DNo Rating Change2.60
4 Jun 2026CRISIL Ratings LimitedBank FacilitiesShort-term scaleCrisil DNo Rating Change3.30
4 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleCrisil DNo Rating Change0.50
4 Jun 2026CRISIL Ratings LimitedBank FacilitiesLong-term scaleCrisil DNo Rating Change6.70
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.